Icon
Intuitive Ventures
Portfolio
Ventures Team
Contact Us
LinkedIn
Future-Tense Investing
Our portfolio companies boldly pursue innovation.
XII Medical is a clinical-stage medical technology company developing innovative neuromodulation therapies for obstructive sleep apnea.
xiimedical.com
Open new window
Amber Therapeutics is a clinical-stage company developing a fully implantable, closed-loop neuromodulation therapy designed to treat mixed urinary incontinence (MUI).
amber-tx.com
Open new window
Capstan is pioneering a robotic assisted catheter platform and custom heart valves implants.
capstanmedical.com
Open new window
Endogenex develops Pulsed Electric Field–based device therapies for the treatment of gastrointestinal and metabolic diseases.
endogenex.com
Open new window
Flywheel is an Enterprise medical imaging data management and analysis platform to support research, clinical trials and AI model development at scale.
flywheel.io
Open new window
KelaHealth provides an advanced surgical AI platform and perioperative clinical decision support tools.
kelahealth.com
Open new window
Medcrypt helps medtech companies meet and exceed FDA’s cybersecurity requirements, getting devices approved faster.
medcrypt.co
Open new window
Neocis has an FDA-cleared robotic surgical system for high precision dental implants.
neocis.com
Open new window
FDA-cleared AI decision-support software to assist clinicians in early diagnosis and optimal treatment of lung cancer by identifying and risk-stratifying pulmonary nodules.
optellum.com
Open new window
Surge is a clinical stage company developing injectable, biodegradable hydrogels to deliver localized immunotherapy directly into a surgical site after tumor removal.
surgetx.com
Open new window
testing